Home › Funds › Maverick Capital › TECH

Maverick Capital position in TECH

Bio-Techne Corp. · Health Care

Maverick Capital reported holding 1,535,610 shares of TECH (Bio-Techne Corp.) in its Q3 2026 13F filing — a position valued at US$111.3M, representing 0.91% of its reported portfolio and ranking #32 among its reported holdings. Maverick Capital has disclosed TECH holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)1.54M sh
Reported value held$111.29M
Portfolio Weight0.91%
First reportedQ1 2025
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Maverick Capital's TECH position evolved

Maverick Capital first disclosed a stake in TECH in Q1 2025 at 522,897 shares (US$30.7M). The position peaked in Q1 2026 at 4,739,721 shares, worth US$247.7M. Across 6 filings, Maverick Capital increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,535,610 shares valued at US$111.3M. Notable position changes include a 28% increase in Q4 2025 (shares fell 11% over the following quarter), a 68% trim in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 522.90K $30.66M New
Q3 2025 3.01M $167.59M New
Q4 2025 3.85M $226.47M Add
Q1 2026 4.74M $247.70M Add
Q2 2026 1.54M $108.49M Reduce
Q3 2026 1.54M $111.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (Bio-Techne Corp.) is a Health Care company. 27 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$560.3M), Balyasny Asset Management (US$246.7M), Ruane Cunniff & Goldfarb (Sequoia) (US$242.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has Maverick Capital held TECH?

Maverick Capital has disclosed TECH holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

What is Maverick Capital's current position in TECH?

As of Q3 2026, Maverick Capital holds 1.54M shares of TECH (Bio-Techne Corp.), valued at $111.29M, representing 0.91% of its reported portfolio and ranking #32.

Has Maverick Capital been buying or selling TECH?

In the latest 13F filing (Q3 2026), Maverick Capital held unchanged its position in TECH. The position peaked in Q1 2026 at 4.74M shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Balyasny Asset Management, Ruane Cunniff & Goldfarb (Sequoia), among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.